Word: biotech
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...simplicity. The problem is, once the donor organ is stitched in place, the body rebels, rejecting it even more violently than it would a human graft. "A pig heart transplanted in a person would turn black within minutes," says David Ayares, a research director with PPL Therapeutics, the biotech firm based in Scotland, New Zealand and Virginia that helped clone Dolly and also produced the piglets...
Relatives of the gynecologist, Dr. Larry Ford, who was a partner in a small biotech firm, had told police of the weapons cache, and police feared the canisters might contain dangerous biological or chemical compounds. A local newspaper had linked Ford to South Africa's biological-weapons program. So before police searched Ford's property, they closed a nearby elementary school and evacuated about 50 families from the neighborhood, putting them up at a local Hyatt Regency. One of the neighbors, a balding, middle-aged man loading up a van for a family ski trip, shook his head in bewilderment...
...company behind the experiments. Although moral critics of the practice will blanch, the purpose of PPL's cloning experiments - the latest being conducted by the company's U.S. division, in Blacksburg, Va., with a federal government research grant - has been directed not at creating photocopy humans, but at developing biotech donor organs. The company announced it would begin clinical trials of porcine organ transplants in about four years, and its stock price (listed in London) rose by a record 19 percent on the news...
Just saying yes has been a smart play. Up an unprecedented 86% last year, the index known for its high-tech and biotech wonders is up an additional 21% this year. It hit a new high Friday as the Dow struggled to stanch a 16% decline. The two market gauges have diverged dramatically all year, going in opposite directions on half of all trading days. Such an extreme divide has occurred only seven previous times in 30 years, according to Bianco Research, and in this case illustrates the extent to which investors are dumping old-economy stalwarts in favor...
...president of the antibiotech Foundation on Economic Trends and no stranger to street theater, agrees that when it comes to protesting, less can be more. "If you go too far," he says, "nobody pays attention." On the other hand, it's hard to argue with results. In December the biotech giant Novartis announced that it was washing its hands of agritech. And last week delegates at the Montreal conference agreed to require labeling of all genetically modified goods...